Protillion Biosciences Raises $18 Million Series A Financing Led By Arch Venture Partners And Illumina Ventures
Amount Raised
$18 Million
Round Type
Series A
BurlingameOtherBiotechnologyHealth CareInvestors
Description
Protillion Biosciences, a privately held biotech company working to identify and optimize new protein therapeutics and accelerate biologic research and development productivity, today announced the completion of an $18 million Series A financing from ARCH Venture Partners and Illumina Ventures. The Company's platform enables its commercial drug discovery partners to perform true quantitative analysis on complete protein libraries, producing actionable insights in days; a process that can take months using current industry best practices. Protillion's proprietary technology can generate and analyze massive experimental datasets at perfect amino acid resolution, enabling novel machine-learning approaches to antibody and binder discovery.
Quick answer
Protillion Biosciences raised $18 Million in a Series A round, dated December 19, 2022. Investors: Illumina Ventures and ARCH Venture Partners. Protillion Biosciences is based in Burlingame, California, United States.
- How much did Protillion Biosciences raise?
- Protillion Biosciences raised $18 Million in a Series A round on December 19, 2022.
- Who invested in Protillion Biosciences?
- Illumina Ventures and ARCH Venture Partners are named as investors in this round.
- What does Protillion Biosciences do?
- Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery.
- Where is Protillion Biosciences based and how big is it?
- Protillion Biosciences is based in Burlingame, California, United States.
- Who are the decision-makers at Protillion Biosciences?
- Fundz holds 1 contact at Protillion Biosciences, including the Head of Finance and Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Protillion Biosciences that raised within 45 days of this round, from Fundz verified event records.
- CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
- Syntach AB raised $19M (Funding Round) on January 30, 2023.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M on January 26, 2023.
- HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
Who to call at Protillion Biosciences, and when
A new round usually means Protillion Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Protillion Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Protillion Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Protillion Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Protillion Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansProtillion Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.